HomeMedicines from Europe › Conbriza (Bazedoxifene) 20 mg, 28 tablets

Conbriza (Bazedoxifene) 20 mg, 28 tablets: profile, composition and research

Reference page for Conbriza (Bazedoxifene) 20 mg, 28 tablets. Active substance: Базедоксифен / Bazedoxifene.

In short

Key facts

Active substanceBazedoxifene
FormFilm-coated tablets
Strength20 mg per tablet
Pack size28 tablets
CategoryPrescription medicine
Article (SKU)
Conbriza (Bazedoxifene) 20 mg, 28 tablets
Price, availability and delivery terms: on the pharmacy site
View at APV Pharmacy

What bazedoxifene is

Bazedoxifene is the active substance of Conbriza. It belongs to the group of selective oestrogen receptor modulators, known in the literature by the abbreviation SERM.

Such substances do not act in the same way in every tissue. In bone they behave similarly to oestrogen, while in the breast and uterus they weaken its influence instead. That selectivity is what separates them from hormone replacement therapy.

Bazedoxifene is used in women after menopause, when bone density falls and the risk of fracture rises. The substance belongs to the third generation of its group and is supplied as 20 mg tablets.

How bazedoxifene works

Receptor binding

The molecule binds to oestrogen receptors in bone tissue and triggers a signal similar in effect to the body's own oestrogen.

Effect on bone

The activity of the cells that break bone tissue down is reduced. Bone loses mineral density more slowly, and this is one of the mechanisms behind fracture protection.

Differences by tissue

In the breast and endometrium the medicine does the opposite and blocks the oestrogen signal. That is why it is not classed as hormone replacement therapy and is not used to relieve hot flushes.

Approved uses

The prescribing information lists the medicine for the treatment of osteoporosis in postmenopausal women who are at increased risk of fracture. The decision to start treatment is made by a physician after assessing bone density and general health.

It matters that Conbriza does not relieve menopausal symptoms such as hot flushes and sweating. It is a medicine for fracture prevention, not a form of hormone replacement therapy.

Treatment is usually combined with adequate calcium and vitamin D intake, physical activity and stopping smoking. Comparative data on bazedoxifene are given in the studies below.

Published research

Primary sources, verified against PubMed:

Listed for reference. Publication of a study is not a claim about this particular product.

Precautions

Frequently asked

Is Conbriza a prescription medicine?

Yes. It is a prescription medicine and is not intended for self-medication.

Does Conbriza replace hormone therapy?

No. It is not hormone replacement therapy and does not relieve hot flushes.

Why does this page not give a dosing schedule?

The regimen is chosen by a physician, taking fracture risk and the patient's condition into account. This reference page does not prescribe treatment.

Where does the order ship from?

Shipping and customs handling are described on the APV Pharmacy delivery page.

Important. This page is reference material and is not medical advice or instruction for use. The product is prescription-only: medical supervision and laboratory monitoring are required. Always consult a qualified healthcare professional.